$10.90
-0.66-5.71%
At close: -
$10.98
0.080.73%
After Hours: 7:52 PM EDT
10x Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 10x Genomics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-12 | $-0.40 | $-0.11 | -263.6 % |
Q3 | 2024-10-29 | $-0.30 | $-0.34 | 11.8 % |
Q2 | 2024-08-08 | $-0.32 | $-0.47 | 31.9 % |
Q1 | 2024-04-30 | $-0.50 | $-0.50 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-12 | $165.02M | $164.98M | 0.02 % |
Q3 | 2024-10-29 | $151.65M | $158.63M | -4.40 % |
Q2 | 2024-08-08 | $153.10M | $150.74M | 1.57 % |
Q1 | 2024-04-30 | $141.01M | $142.24M | -0.87 % |
10x Genomics (TXG) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on February 12, 2025 for Q4.
The Actual EPS was $-0.40, which missed the estimate of $-0.11.
The Actual Revenue was $165M, which beat the estimate of $165M.
Browse earnings estimates, EPS, and revenue on all stocks.